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Idiopathic pulmonary fibrosis is a fatal disease without effective therapy or diagnostic test. To investigate a
potential role for cherpesviruses in this disease, 21 paraffin-embedded lung biopsies from patients diagnosed
with idiopathic pulmonary fibrosis and 21 lung biopsies from age-matched controls with pulmonary fibrosis of
known etiology were examined for a series of cherpesviruses’ DNA/RNA and related proteins using in situ
hybridization and reverse transcriptase-polymerase chain reaction (RT-PCR)-based methods. We detected four
proteins known to be in the genome of several cherpesviruses (cyclin D, thymidylate synthase, dihydrofolate
reductase, and interleukin-17) that were strongly co-expressed in the regenerating epithelial cells of each of the
21 idiopathic pulmonary fibrosis cases and not in the benign epithelia of the controls. Among the c
herpesviruses, only herpesvirus saimiri expresses all four of these ‘pirated’ mammalian proteins. We found
herpesvirus saimiri DNA in the regenerating epithelial cells of 21/21 idiopathic pulmonary fibrosis cases using
four separate probe sets but not in the 21 controls. RT-PCR showed that the source of the cyclin D RNA in active
idiopathic pulmonary fibrosis was herpesvirus saimiri and not human. We cloned and sequenced part of
genome corresponding to the DNA polymerase herpesvirus saimiri gene from an idiopathic pulmonary fibrosis
sample and it matched 100% with the published viral sequence. These data are consistent with idiopathic
pulmonary fibrosis representing herpesvirus saimiri-induced pulmonary fibrosis. Thus, treatment directed
against viral proliferation and/or viral-associated proteins may halt disease progression. Further, demonstra-
tion of the viral nucleic acids or proteins may help diagnose the disease.
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The (gamma) g-herpesvirus family is a candidate for
causing idiopathic pulmonary fibrosis in humans.
Specifically, g-herpesviruses cause pulmonary fibro-
sis in horses (equine herpesvirus 5)1 and donkeys
(asinine herpesvirus)2 that clinically resemble
idiopathic pulmonary fibrosis in humans. Murine
herpesvirus-68 (MHV68),3 a g-herpesvirus that is
closely related to herpesvirus saimiri, is used to
cause pulmonary fibrosis in mice4 that was
successfully arrested with antiviral therapy;5 this
is the only recognized viral animal model of
idiopathic pulmonary fibrosis.
Herpesvirus saimiri is a g2-herpesvirus that is non-
pathogenic in its natural host, the squirrel monkey
(Saimiri sciureus), but causes fatal T-cell lympho-
mas and leukemias in New World monkeys.6 In
vitro, it infects a wide variety of human cell types7–9
and transforms Rat-1 cells to form foci in culture.10
Subclinical infections in humans may be common,
as an estimated 4.0–7.3% of people are seropositive
for herpesvirus saimiri.11 Productive infection by
herpesvirus saimiri is associated with the co-expres-
sion of viral DNA with several pirated mammalian
proteins such as interleukin-17 (IL-17),12,13 viral
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cyclin D,14 thymidylate synthase,15 and dihydro-
folate reductase.16
About 200 000 in the United States of America
have idiopathic pulmonary fibrosis, which is typi-
cally fatal within 2 years of diagnosis and with no
diagnostic test.17 Idiopathic pulmonary fibrosis does
not respond to combined immunosuppressive and
systemic steroid therapy, which may worsen the
symptomatology.18 Other common treatment
combinations have also failed to show efficacy in
multicenter clinical trials.19 The theoretical possi-
bility of infectious etiology for idiopathic pulmo-
nary fibrosis is currently being re-examined.20
Our recent work revealed the unique role that
regenerating epithelial cells have in idiopathic
pulmonary fibrosis.21 These cells are the primary
sources of a variety of immunomodulating proteins
in idiopathic pulmonary fibrosis, including IL-17, a
cytokine that was discovered in activated T cells,13
with high homology to a gene in herpesvirus
saimiri.12 Here, we report a likely etiologic role of
herpesvirus saimiri in idiopathic pulmonary fibrosis
in humans by showing a strong co-expression of IL-
17, cyclin D1, thymidylate synthase, and dihydro-
folate reductase with the viral DNA. In pulmonary
fibrosis of known etiology, there is lack of herpe-
svirus saimiri DNA, and there is an absence of
co-expression of herpesvirus saimiri-pirated
proteins in a large series of benign and malignant
diseases of the lung. We also report the demon-
stration by RT-PCR that the cyclin D in idiopathic
pulmonary fibrosis is expressed from the
corresponding gene of herpesvirus saimiri and not
from the human host, and the cloning and sequen-
cing of a part of the viral DNA polymerase gene from
a clinical sample of idiopathic pulmonary fibrosis
that revealed a 100% match with the published
sequence of herpesvirus saimiri.22
Materials and methods
Patient Samples
The patient samples (formalin-fixed biopsies) from
the files of Weill Cornell Medical Center or the
Medical College of Wisconsin had an IRB-approved
protocol that de-identified all data except for the
diagnosis, age, extent of negative workup, and sex of
the patient. Twenty-one cases of idiopathic pulmon-
ary fibrosis were obtained and were diagnosed as
such after review by clinicians, radiologists, and
pathologists (SS, CM) expert in the field. The
American Thoracic Society and the European
Respiratory Society criteria of idiopathic pulmonary
fibrosis were used that included a histologic diag-
nosis of usual interstitial pneumonitis, abnormal
pulmonary function tests indicative of restrictive
lung disease, abnormal findings on CT scan, age
450 years, duration of illness 43 months, and
exclusion of known causes of interstitial lung
disease. The mean age of the patients was 60.6
years (s.e.m.¼ 2.3 years); 14 were men and 7 were
women. As controls, 21 paraffin-embedded biopsies of
focal lung fibrosis of known cause were studied (mean
age 62.0 with 15 men). These included seven cases of
fibrosis-related adenocarcinoma of the lung, five cases
of lung fibrosis associated with emphysema, and nine
cases of interstitial pneumonitis and fibrosis of known
viral etiology including measles (one case), adenovirus
(three cases), hantavirus (three cases), and rotavirus
(two cases). The lung fibrosis associated with emphy-
sema was chosen to show only focal fibrosis, with no
evidence of co-existing lung disease such as desqua-
mative interstitial pneumonia or usual interstitial
pneumonia. The cases and controls were all from
open lung biopsies. As additional negative and posi-
tive controls, we infected Jurkat cells with herpesvirus
saimiri obtained from the ATCC (catalog no. F28513,
Manassas VA, USA). Three days post transfection,
the cells were fixed in 10% buffered formalin for 5h
and then processed for in situ hybridization.
In Situ Hybridization Analysis
Our in situ hybridization protocol has been pre-
viously described.23 In brief, in situ hybridization
was performed on each of the 21 cases and 21
controls for herpesvirus saimiri. The probes were
LNA (locked nucleic acid)-modified and 50
digoxigenin-tagged (Exiqon). Two separate probe
sets against herpesvirus saimiri were tested: probe
set one was directed against ORF1, the herpesvirus
Saimiri Transforming Protein (STP) oncogene and
had the following sequences: 50-CTCTAAGCACAGG
GGCACAG-30 and 50-CTACGCAGAAGTCGGAAG
CC-30.24 The second probe set was directed against
the 1444-base pair repeat, heavy-DNA (H-DNA) non-
transcribed region, which is present in about 35
copies/viral genome and had the following
sequences: 50-GCCGCCTCAGAATTTTAGCA-30 and
50-CTCTGCGTGAAGCACAGTGC-30.25 These in situ
hybridization tests were performed with serial
sections to compare the same groups of cells. The
majority of the cases were also tested by in situ
hybridization for Epstein-Barr virus (EBV), cytome-
galovirus (CMV), and herpes simplex virus types I/II
(HSVI/II) using biotin-labeled probes from Enzo Life
Sciences. The probe/target complex was visualized
after the alkaline phosphatase-linked conjugate
reacted with the chromogen, nitroblue tetrazolium,
and bromochloroindolyl phosphate (NBT/BCIP)
with a nuclear fast red counterstain. Negative
controls included omission of the probe, use of a
scrambled probe, non-infected Jurkat cells, and the
21 cases of lung fibrosis of known etiology.
Immunohistochemical Analysis
Our immunohistochemical protocol has been
previously described (Leica BOND-MAX).23 We
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analyzed for the latent membrane protein (LMP) of
EBV, the latent nuclear antigen (LNA-1) of Kaposi’s
associated herpesvirus (KSHV), and CMV proteins
8B1.2, 1G5.2, and 2D4.2. As productive infection by
herpesvirus saimiri is associated with the
expression of several pirated mammalian proteins,
including viral cyclin D, thymidylate synthase, IL-
17, and dihydrofolate reductase, and as each of these
four proteins shares sufficient homology with the
counterpart human protein to be detected using
immunohistochemistry,6 we also analyzed the cases
and the controls for each of these four proteins.
Co-expression Analysis
Our co-expression analysis protocol has been pre-
viously reported.21,23 The computer-based analysis
by the Nuance system (Caliper) separates each chro-
mogenic spectral signal, converts it to a fluorescent
signal, then mixes the two and indicates whether
cells contain the two targets of interest.
Reverse Transcriptase-Polymerase Chain Reaction
(RT-PCR)
Total RNA was extracted from paraffin samples
using the RecoverAll Total Nucleic Acid Isolation
Kit (AM1975, Ambion) according to the manufac-
turer’s instructions. cDNA was generated from this
RNA using SuperScript III First-Strand Synthesis
SuperMix Kit (18080400, Invitrogen) using the
following primers:
Human Cyclin D1 50-CGGAGGAGAACAAACA
GATCATCCGCAAAC-30, 50-GTGTGAGGCGGTAGTA
GGACAGGAAGTTGT-30; Viral Cyclin D 50-ACTGCT
TACCTGGATGCATCTGCTCTGTGA-30, 50-GCAAGT
ACAGCTTCAGTGTGTCCCATTTCAGTGC-30.
Figure 1 Histopathological and molecular correlates of idiopathic pulmonary fibrosis. a–c (hematoxylin and eosin) show increased
magnifications of idiopathic pulmonary fibrosis in which areas of histologically normal lung is admixed with areas of active fibrosis (a,
 25), marked by serpentine glands lined with epithelia (b, 50), which show nuclear atypia and multinucleation (c, arrow,  400).
Herpesvirus saimiri DNA was commonly detected in the nuclei of the epithelia of these serpentine glands (d, 50) and much less
evident in the admixed histologically normal lung (e,  400; blue NBT/BCIP signal with pink counterstain). In comparison, herpesvirus
saimiri DNA was not evident in cases of interstitial pneumonitis and fibrosis of known viral etiology (f,  400 measles infection).
Herpesvirus saimiri DNA was evident in the regenerating epithelia in idiopathic pulmonary fibrosis in the same cells when serial
sections were probed for herpesvirus saimiri terminal repeat sequence (g, 400) or the STP ORF 1 gene (h, 400).
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The viral and human primers share no homology.
PCR was conducted with Ex Taq DNA Polymerase
(RR01A, Takara) and the primers are listed above.
Results
Initially, we addressed the question of whether
idiopathic pulmonary fibrosis was associated with
any herpesvirus infection. We screened 13 cases of
idiopathic pulmonary fibrosis via in situ molecular
pathology analyses for different g-herpesviruses and
HSV I/II. Each case was negative for EBV, CMV,
Kaposi’s sarcoma herpes virus, and HSV I/II. Each of
the 13 idiopathic pulmonary fibrosis cases was
positive for herpesvirus saimiri DNA. We expanded
the study to a total of 21 cases of idiopathic
pulmonary fibrosis and 21 cases of age-matched
controls, which showed pulmonary fibrosis of
known etiology. When read blinded to the diagnosis,
21/21 of idiopathic pulmonary fibrosis cases were
positive for herpesvirus saimiri DNA by in situ
hybridization, whereas 0/21 of the control cases of
pulmonary fibrosis was herpesvirus saimiri DNA-
positive. Further, the Jurkat cells infected by the
virus showed an intense nuclear signal in the
majority of the malignant cells, whereas the non-
infected cells had no signal (data not shown).
The herpesvirus saimiri DNA distribution closely
paralleled the histopathology of usual interstitial
pneumonitis that is evident in idiopathic pulmon-
ary fibrosis (Figures 1a–c). Herpesvirus saimiri-
positive nuclei were evident in many of the
regenerating epithelial cells in the areas of active
and early fibrosis (Figure 1d, g and h). Although the
histologically normal lung in idiopathic pulmonary
fibrosis was often viral-negative, rare viral DNA-
positive pneumocytes were at times evident
(Figure 1e). Virus-positive cells were not evident in
the areas of end-stage fibrosis of idiopathic pulmon-
ary fibrosis, which lacked epithelial cells, or in the
regenerating epithelial cells of interstitial pneumo-
nitis with fibrosis of known etiology (Figure 1f).
High magnification (Figure 1c) showed that the
herpesvirus saimiri-positive epithelial cells often
showed nuclear atypia and, at times, multinucleation.
The different g-herpesvirus members show a
similar genetic organization and share homology
over various parts of their genomes.6,22,26,27 The
probe set used for the initial evaluation used two
Figure 1 (Continued)
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probes for the herpesvirus saimiri-specific onco-
gene, STP. A BLAST sequence analysis showed that
probe 1 shared weak homology with some human
genes, whereas probe 2 had no such homology.
In situ hybridization was performed on serial sections
using probe 1 and probe 2 separately in five cases. In
each case, STP probe 1 and STP probe 2 resulted in a
signal in the same group of regenerating epithelial
cells (data not shown). Further, we separated the two
LNA probes targeting the 1444-base pair DNA repeat
region of herpesvirus saimiri (H-DNA region) and
analyzed the serial sections of another set of five cases
of idiopathic pulmonary fibrosis. In each case,
individual probes corresponding to the H-DNA viral
region yielded signals in the same groups of
regenerating epithelial cells as the probe cocktail
containing both H-DNA probes 1 and 2 (data not
shown). Similarly, testing serial sections of idiopa-
thic pulmonary fibrosis with the H-DNA and
STP probe sets showed the same viral distribution
in the adjacent sections (Figure 1, panels G and H,
respectively).
The data showing a strong nuclear-based signal in
the proposed target cell of idiopathic pulmonary
fibrosis are consistent with a productive viral infec-
tion, as any herpes virus infection is invariably
nuclear-based. To seek additional evidence, we
analyzed serial sections of the cases of idiopathic
pulmonary fibrosis that had sufficient tissue for
known herpesvirus saimiri-pirated mammalian pro-
teins including IL-17, cyclin D, thymidylate syn-
thase, and dihydrofolate reductase with matching
negative controls. When examined blinded to the
diagnosis, in each of the idiopathic pulmonary
Figure 2 Expression of herpesvirus saimiri-related proteins in idiopathic pulmonary fibrosis. a ( 100, fast red stain and hematoxylin
counterstain) and, at higher magnification, b (400) show that cyclin D1 is highly expressed in the regenerating epithelial cells of
idiopathic pulmonary fibrosis. c ( 100) shows the same pattern of localization for dihydrofolate reductase to the regenerating epithelia
in the areas of active fibrosis of idiopathic pulmonary fibrosis and the rarity of the protein in the adjacent normal areas of the same lung
tissue (d, 200). The tissues in e–h (each at 400) represent photographs of the same cells in serial sections of a case of idiopathic
pulmonary fibrosis. The samples were analyzed for either herpesvirus saimiri using an probe specific for the IL-17 DNA sequence (e, f) or
the herpesvirus saimiri DNA polymerase gene (g, h). After in situ hybridization, co-expression analysis was performed using
immunohistochemistry with either cyclin D (e, f) or dihydrofolate reductase (g, h). In each case, the signal for the DNAwas blue and the
protein was brown; the Nuance-merged image shows the DNA as fluorescent blue and the protein as fluorescent green, whereas cells
with both targets show fluorescent yellow. Note that the same pattern of co-expression is seen in e–h in the merged images.
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fibrosis cases, there was marked overexpression of
cyclin D (Figures 2a and b), dihydrofolate reductase
(Figure 2c), thymidylate synthase, and IL-17. Note
the equivalent distribution patterns for the viral-
associated proteins and herpesvirus saimiri DNA as
they localized to the regenerating epithelial cells in
areas of active fibrosis. Further, the proteins were
much less evident in the epithelia of the histologi-
cally unremarkable lung in the idiopathic pulmon-
ary fibrosis cases (Figure 2d).
The protein and herpesvirus saimiri DNA data are
presented in Table 1. Note that expression levels of
cyclin D1, thymidylate synthase, and dihydrofolate
reductase were much less evident in interstitial
pneumonitis and fibrosis of known viral etiology or
in the fibrosis associated with emphysema or
adenocarcinoma when compared with idiopathic
pulmonary fibrosis. Although these proteins were
commonly detected in the adenocarcinoma cells,
they were rarely present in the regenerating lung
epithelia and desmoplasia present at the tumor-
benign lung interface (data not shown). Importantly,
none of the controls had any of the four proteins co-
expressed by the same cells. Also note that Table 1
includes the serial section analysis of 41 benign
stromal tumors, 34 sarcomas, and 44 non-small cell
carcinomas of the lung. Note that the majority of the
lung cancers and sarcomas were associated with
dihydrofolate reductase expression. However, not
one sarcoma, carcinoma, or control case demon-
strated co-expression for dihydrofolate reductase
and cyclin D or IL-17. Thus, the co-expression of
dihydrofolate reductase, cyclin D, thymidylate
synthase, and IL-17 proteins seemed to be unique
to idiopathic pulmonary fibrosis.
We cloned parts of the herpesvirus saimiri
genome corresponding to the DNA polymerase and
IL-17 viral genes, given that the former is well con-
served among the herpesvirus saimiri strains and
the latter is specific for herpesvirus saimiri. These
clones were used to generate biotin-labeled probes
that were tested on selected cases of idiopathic
pulmonary fibrosis and matching controls. When
tested in serial sections, the probes for the STP, IL-17,
DNA polymerase, and terminal repeat viral se-
quences yielded signals in the same regenerating
epithelial cells in idiopathic pulmonary fibrosis
(Figures 2e–h) and not in the negative controls. Co-
expression analysis also showed that the same sets of
cells that were expressing these viral DNA sequences
co-expressed cyclin D (Figures 2e–h, respectively).
To obtain further evidence of the strong co-
expression in idiopathic pulmonary fibrosis, we
performed direct co-expression analysis of the viral
DNAwith dihydrofolate reductase, cyclin D, thymi-
dylate synthase, and IL-17 in the 18 idiopathic
Figure 2 (Continued)
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pulmonary fibrosis cases where sufficient tissue
remained. As seen in Figure 3, co-expression
analysis confirmed that epithelial cells in the active
areas of idiopathic pulmonary fibrosis that were
positive for viral DNA were also co-expressing the
herpesvirus saimiri-pirated proteins (Figures 3a
and b, herpesvirus saimiri DNA and thymidylate
synthase; Figures 3c and d, herpesvirus saimiri DNA
and IL-17; Figure 3e and f cyclin D1 and herpesvirus
saimiri DNA (STP probe set); and Figure 3g and h,
cyclin D1 and herpesvirus saimiri DNA, H-DNA
probe set). We also had positive co-expression for
Table 1 Quantification and co-expression of herpesvirus saimiri DNA, cyclin D1, dihydrofolate reductase, IL-17, and thymidylate
synthase in idiopathic pulmonary fibrosis, interstitial pulmonary fibroses of known etiology, non-small cell lung carcinomas, and
sarcomas
Case
Histology
active
fibrosis
HVS
DNAa
Cyclin
D1a
Dihydrofolate
reductasea
IL-
17a
Thymidylatea
synthase Co-expressionb Nuance
IPF1 3þ 3þ 3þ 3þ 3þ 3þ 3þ HVS-DNAþ cyclin D1
IPF2 3þ 3þ 3þ 3þ 3þ 3þ 3þ HVS-DNAþDHFR
IPF3 3þ 3þ 3þ 3þ 3þ 3þ 3þ DHFRþ cyclin D1
IPF4 3þ 3þ 3þ 3þ 3þ 3þ 3þ HVS-DNAþ cyclin D1
IPF5 3þ 3þ 3þ 3þ 3þ 3þ 3þ DHFRþ cyclin D1
IPF6 3þ 3þ 3þ 3þ 3þ 3þ 3þ HVS DNA1þ IL-17
IPF7 3þ 3þ 3þ 3þ 3þ 3þ 3þ HVS-DNAþ cyclin D1
IPF8 3þ 3þ 3þ 3þ 3þ 3þ 3þ HVS- DNAþTS
IPF9 3þ 3þ 3þ 3þ 3þ 2þ 3þ HVS-DNAþ cyclin D1
IPF10 3þ 3þ 3þ 3þ 3þ 2þ 3þ HVS-DNAþ -AE1/3
IPF11 2þ 2þ 2þ 2þ 2þ 2þ 3þ DHFRþ cyclin D1
IPF12 2þ 2þ 2þ 2þ 3þ 2þ 3þ HVS DNA1þ IL-17
IPF13 2þ 2þ 2þ 2þ 2þ 2þ 3þ HVS S-DNAþ cyclin D1
IPF14 2þ 2þ 2þ 2þ 3þ 2þ 3þ HVS S-DNAþAE1/3
IPF15 2þ 2þ 2þ 2þ 2þ ND 3þ HVS S-DNAþAE1/3
IPF16 2þ 2þ 2þ 2þ 2þ 2þ 3þ HVS DNA1þ IL-17
IPF17 2þ 2þ 2þ 2þ 2þ ND 3þ cyclin D1þ IL-17
IPF18 2þ 2þ 2þ 2þ ND ND ND
IPF19 2þ 2þ 2þ 2þ ND 2þ 3þ cyclin D1þTS
IPF20 1þ 1þ 1þ 1þ 2þ 1þ ND
IPF21 1þ 1þ 1þ 1þ 2þ 1þ ND
Case Histology
HVS
DNAa
Cyclin
D1a
Dihydrofolatea
reductase
IL-
17a
Thymidylatea
synthase
Co-
expressionb
Control 1 IP-V 0 0 1þ 2þ 0 None
Control 2 IP-V 0 0 1þ 1þ ND None
Control 3 IP-V 0 1þ 0 ND 1þ None
Control 4 IP-V 0 0 0 3þ 1þ None
Control 5 IP-V 0 0 2þ 2þ ND None
Control 6 IP-V 0 ND 0 0 1þ NA
Control 7 IP-V 0 1þ 0 0 3þ NA
Control 8 IP-V 0 0 ND 2þ 1þ NA
Control 9 IP-V 0 0 0 2þ 1þ None
Control 10 Adenocarcinoma 0 2þ 2þ ND 1þ None
Control 11 Adenocarcinoma 0 1þ 1þ 2þ ND None
Control 12 Adenocarcinoma 0 0 3þ 1þ 0 None
Control 13 Adenocarcinoma 0 2þ 0 0 2þ None
Control 14 Adenocarcinoma 0 3þ 1þ ND 2þ None
Control 15 Adenocarcinoma 0 2þ 3þ 0 1þ None
Control 16 Adenocarcinoma 0 1þ 3þ 2þ 2þ None
Control 17 COPD 0 0 ND ND 0 NA
Control 18 COPD 0 0 ND 1þ ND NA
Control 19 COPD 0 0 0 0 1þ NA
Control 20 COPD 0 0 ND 0 1þ NA
Control 21 COPD 0 ND 0 ND 0 NA
TMAs: Histology HVS DNA Cyclin D1c DHFRc IL-17c Co-expressionc
Benign stromal tumors 0/41 5/41 (12%) 16/41 (39%) 6/41 (15%) 0/41
Malignant stromal tumors 0/34 9/34 (26%) 28/34 (82%) 5/34 (15%) 0/34
Non-small cell lung cancer 0/44 13/44 (29%) 26/44 (59%) 23/44 (52%) 0/44
Abbreviations: COPD, chronic obstructive pulmonary disease; DHFR, dihydrofolate reductase; HSV, herpes simplex virus; HVS, herpesvirus
saimiri; IPF, idiopathic pulmonary fibrosis; IP-V, Interstitial pneumonitis due to known viral infection; NA, not applicable; ND, not done.
aScores for DNA and proteins were read as 0, 1þ (1–19% of regenerating epithelial cellsþ for target), 2þ (20–39%þ cells), and 3þ (40% or
greaterþ cells).
bScores for co-expression were read as 0, 1þ (1–29% cells with two targets), 2þ (30–50% cells with two targets), and 3þ (majority of cells co-
expressing two targets).
cAny given TMA core was scored as positive if at least 20% of tumor cells expressed the target protein.
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herpesvirus saimiri and cytokeratin AE1/3 (a marker
of regenerating epithelial cells), demonstrating that
essentially all of the viral DNA-positive cells
were indeed cytokeratin-positive (data not shown).
Finally, co-expression analysis of cyclin D1 with
thymidylate synthase, IL-17, and dihydrofolate
reductase confirmed that basically all of the regen-
erating epithelial cells expressing cyclin D1 were
also expressing the other three viral-related proteins
(Figure 4).
We next extracted the RNA from five samples to
determine whether the cyclin D RNA that was
highly expressed in idiopathic pulmonary fibrosis
was viral, human, or both in origin. We were limited
to five samples as we only had formalin-fixed,
paraffin-embedded tissues in each control and each
idiopathic pulmonary fibrosis case, except for one
case where frozen unfixed tissue was available. For
many of the samples, we used most of the block for
the in situ-based analyses and only five yielded
sufficient RNA for RT-PCR. We chose to study cyclin
D RNA, as it has the least homology between human
and viral genes (23%) of the four pirated genes,
making it straightforward to design primers with no
homology between the corresponding human and
viral cyclin RNA sequences. The viral-specific
amplicons derived from RTPCR were 290 nucleo-
tides, whereas the human-specific amplicons were
180 nucleotides. When analyzed blindly (Figure 4),
the case with no idiopathic pulmonary fibrosis
(normal lung adjacent to cancer, lane 2392) showed
a human cyclin D1 cDNA band and no viral band.
Case 21565, which was a histologically normal lung
from a case of idiopathic pulmonary fibrosis that
showed no viral DNA on in situ hybridization, also
showed a human cyclin D1 and no viral band. The
two cases of active idiopathic pulmonary fibrosis
with a 2þ viral copy number (39B and 51-1)
showed primarily viral cyclin D cDNA amplicons.
The one case of active idiopathic pulmonary fibrosis
Figure 3 Co-expression analysis of herpesvirus saimiri DNA and related proteins in idiopathic pulmonary fibrosis. Each set of panels
shows the RGB image (a, c, e, and g) and the Nuance-derived image (b, d, f, and h) after co-expression analysis of viral DNA (blue in the
RGB image and fluorescent blue in the Nuance image) and the protein (DAB for a and c and fast red for e and g; each protein is fluorescent
red in the Nuance image). Fluorescent yellow in b, d, f, and h reflects co-expression of the viral DNA and the protein; each image is
at 400. Herpesvirus saimiri DNA strongly co-expressed with thymidylate synthase (a, b), IL-17 (c and d), and cyclin D1 (e and f). e/f
and g/h are serial sections in which the same cells were analyzed for co-expression for cyclin D1 and the herpesvirus saimiri DNA
STP gene (e and f) and the terminal repeat sequence (g and h), respectively.
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that showed 3þ viral DNA with 3þ expression of
cyclin D upon immunohistochemistry (Figure 4)
showed the most intense band with the viral-
specific cyclin D primers and no band with the
human-specific cyclin D1 primers. Thus, there was a
good correlation between the in situ findings of
herpesvirus saimiri DNA detection and the viral
origin of the cyclin D RNA.
Finally, we used the DNA extracted from the
frozen, fixed tissue of idiopathic pulmonary fibrosis
in PCR analysis to amplify part of the herpesvirus
saimiri DNA polymerase gene. An H&E-stained
section of the tissue from the case confirmed both
idiopathic pulmonary fibrosis and many regenerat-
ing epithelial cells positive for the virus DNA and
viral-related proteins (Figure 4, panel C). After
amplifying the DNA, we cloned and sequenced it.
The sequence of the amplicon internal to the
primers (50-GGGTGCGAGCGTATGTGTTAACGTG
TTTGGACAAAGAAATTACTTTTATGT-30) was a
100% match with the reported sequence of herpes-
virus saimiri strain C488 and shows only one-base
pair mismatch with strain A11 of herpesvirus
saimiri,22 as would be expected when sequencing
a well-conserved region of herpesvirus saimiri.
Discussion
A primary finding of this study is that thymidylate
synthase, dihydrofolate reductase, IL-17, and a viral
cyclin D1 homolog are strongly co-expressed in the
regenerating epithelial cells that are orchestrating
the pathophysiology of idiopathic pulmonary fibro-
sis and not in the epithelia of non-idiopathic
pulmonary fibroses including multiple cases of
interstitial pneumonitis and fibrosis of known viral
etiology. Among the g-herpesviruses, the combina-
tion of these proteins is unique to herpesvirus
saimiri. We have shown that herpesvirus saimiri
DNA, using four separate probes corresponding to
different regions of the viral genome, and each of
these four pirated mammalian proteins, co-localized
to the regenerating epithelial cells of idiopathic
pulmonary fibrosis. We chose to examine the cyclin
D RNA as the sequences are most disparate when
comparing viral to human sequences. RT-PCR
demonstrated that the primary source of cyclin D
in active idiopathic pulmonary fibrosis is from
herpesvirus saimiri and not from the human host.
We were able to clone the DNA from a patient’s
idiopathic pulmonary fibrosis sample using PCR
Figure 3 (Continued)
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and primers from the viral DNA polymerase chain
gene. When the clone was sequenced, it revealed a
perfect match with the reported sequence for
herpesvirus saimiri.
The data suggest that the detection of these
proteins and viral DNA in a patient with pulmonary
fibrosis would be diagnostic of idiopathic pulmon-
ary fibrosis and, importantly, may help in dictating
effective therapy. In this regard, there are reports in
both human idiopathic pulmonary fibrosis28 and the
murine model of PF,5,29 in which anti-herpesvirus
treatment was effective in halting disease progre-
ssion. Further, rapamycin therapy, which inhibits
cyclin D1 activity,30 has been shown to stop disease
progression in a human case of idiopathic
pulmonary fibrosis31 and in a murine model of this
disease.32
Herpesvirus saimiri is a member of the g-herpes-
virus subfamily that shares the same genetic orga-
nization as other members that are strongly
associated with human disease, including EBV,
CMV, and Kaposi’s sarcoma herpes virus.6 The
genomes of these viruses are very large (B160 kb)
and are arranged in a series of ORFs that comprise
83 potential genes. Although all herpesvirus family
members have incorporated DNA sequences that
share homology with mammalian sequences, herpe-
svirus saimiri is notable for having the largest
Figure 4 Detection of viral cyclin RNA using RT-PCR analysis in idiopathic pulmonary fibrosis. In a, it is evident that samples 2392
(negative for idiopathic pulmonary fibrosis) and 21565 (histologically normal area of idiopathic pulmonary fibrosis case with no
detectable viral DNA) showed only human cyclin D1 cDNA amplicons after RT-PCR (viral amplicon 290 nucleotides and human
amplicon 180 nucleotides). In comparison, the RNA extracted from two cases of idiopathic pulmonary fibrosis with active fibrosis and
2þ viral DNA (39B1 and 51-1) showed primarily viral cyclin D1 amplicons after RT-PCR analysis. b shows that in an idiopathic
pulmonary fibrosis case with 3þ herpesvirus saimiri DNA (2210), only viral cyclin D RNA sequence is amplified and that the band
intensity is greater than that for the 2þ viral cases shown in a. c shows the strong expression of cyclin D using immunohistochemistry in
case 2210 plus the strong co-expression of cyclin D1 (fluorescent green) and dihydrofolate reductase (fluorescent red) with the merged
image showing co-expression as fluorescent yellow.
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number of pirated human and mammalian DNA
sequences of any known virus.22 Little is known
about the consequences of herpesvirus saimiri
infection in humans. The older age (450 years is a
minor criterion of idiopathic pulmonary fibrosis with
the American Thoracic Society and the European
Respiratory Society criteria) of patients diagnosed
with idiopathic pulmonary fibrosis33 suggests that
reactivation of latent herpesvirus infection may be
occurring as in the well-documented occurrence with
varicella-zoster and shingles.
The histopathology of idiopathic pulmonary
fibrosis is marked by many microscopic areas of
alveolar damage with regenerating epithelial cells
and early fibrosis interspersed with histologically
normal lung and end-stage fibrosis with the loss of
epithelia. This heterogeneous pattern, although
typical of idiopathic pulmonary fibrosis, is not
diagnostic because it can overlap with other causes
of interstitial pneumonitis, including those caused
by a variety of acute viral infections and various
drugs. Further, the histologic pattern of idiopathic
pulmonary fibrosis is consistent with a multifocal
pulmonary infectious process with a temporally
heterogeneous shift from latent to productive infec-
tion in many different foci. The in situmethods used
in this study demonstrated a parallel viral pattern
with rare cells positive for viral DNA as well as the
viral-associated pirated proteins in the normal areas
of idiopathic pulmonary fibrosis, a marked increase
in viral DNA and the pirated proteins in the active
areas of idiopathic pulmonary fibrosis, and the loss
of viral DNA and associated proteins in the
honeycombed areas of end-stage fibrosis.
In sum, these data show that idiopathic pulmon-
ary fibrosis is associated with strong co-expression
of four herpesvirus saimiri-associated proteins,
which were not found in aggregate in either benign
or cancerous lung tissues or in a large series of
sarcomas and that these proteins co-localize with
herpesvirus saimiri DNA. Although the virus is
likely herpesvirus saimiri, we cannot exclude the
possibility of a different thus far undiscovered
g-herpesvirus closely related to herpesvirus saimiri
that shares the DNA and RNA sequences tested in
this project. However, this seems unlikely, as the
PCR-obtained clone from a patient’s idiopathic
pulmonary fibrosis sample showed 100% homology
with the reported sequence of the herpesvirus saimiri
DNA polymerase. Given that idiopathic pulmonary
fibrosis has no effective treatment or specific diag-
nostic test and is typically fatal within several years
of diagnosis,33 these data may provide a diagnostic
test for this disease and offer patients the hope of
stabilization of their disease via treatments directed
against herpesvirus saimiri proliferation.
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